DrugPatentWatch Database Preview
ADDERALL XR 25 Drug Profile
Which patents cover Adderall Xr 25, and when can generic versions of Adderall Xr 25 launch?
Adderall Xr 25 is a drug marketed by Shire and is included in one NDA. There are four patents protecting this drug.
This drug has ten patent family members in eight countries.
The generic ingredient in ADDERALL XR 25 is amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate. There are fifty-four drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate profile page.
Summary for ADDERALL XR 25
| International Patents: | 10 |
| US Patents: | 4 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 6 |
| Bulk Api Vendors: | 1 |
| Clinical Trials: | 33 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | ADDERALL XR 25 at DailyMed |
Pharmacology for ADDERALL XR 25
| Drug Class | Central Nervous System Stimulant |
| Physiological Effect | Central Nervous System Stimulation |
US Patents and Regulatory Information for ADDERALL XR 25
International Patents for ADDERALL XR 25
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Japan | 2008303223 | ➤ Try a Free Trial |
| Austria | 427101 | ➤ Try a Free Trial |
| Japan | 2002527468 | ➤ Try a Free Trial |
| World Intellectual Property Organization (WIPO) | 0023055 | ➤ Try a Free Trial |
| European Patent Office | 1977736 | ➤ Try a Free Trial |
| Spain | 2323910 | ➤ Try a Free Trial |
| Canada | 2348090 | ➤ Try a Free Trial |
| Country | Document Number | Estimated Expiration |
